Enovis™ Continues Expansion of Foot & Ankle Portfolio with Knotless Syndesmotic Repair System
Introducing Enofix™ with Constrictor® Technology; featuring a patented self-locking design to assist with ligament repair
Wilmington, DE, April 11, 2023 – Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced the launch of Enofix™ with Constrictor® Technology, the latest addition to Enovis’ growing suite of foot and ankle products. Enofix™ with Constrictor® Technology is a repair system that demonstrates superior fixation under cyclic loading.1
“Adding a syndesmotic repair device to our portfolio demonstrates Enovis’ commitment to our customers by expanding solutions across the foot and ankle,” said Gary Justak, President and General Manager of Enovis Foot & Ankle. “What is exciting about Enofix™ with Constrictor® Technology is its compatibility with the Arsenal Ankle Plating System™, our comprehensive ankle plating portfolio.”
Enofix™ with Constrictor® Technology provides foot and ankle surgeons with a syndesmotic repair solution featuring a knotless adjustable and low-profile button. The suture is a custom Dunamis Medical® fiber made of UHMWPE.
“Enofix™ with Constrictor® Technology affords excellent flexible stabilization of the syndesmosis,” said Jason Nowak, DPM of Redding, CA. “It is easy to use, deploys smoothly, and gives fantastic syndesmotic fixation. It fits very well within the new Enovis Arsenal Ankle distal fibula plates as well.”
For more product information, please click here.
To stay up to date with Enovis Foot & Ankle news and events, please follow instagram.com/enovisfootankle.
Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com.
About Dunamis Medical®
Established in 2012, Dunamis Medical® specializes in the development of innovative technologies to advance the science of orthopedics. The patented Constrictor® fixation system was designed to optimize suspensory fixation for soft tissue and bone to bone repairs. Constrictor® Technology is a registered trademark of Dunamis Medical LLC and patented under U.S. Pat. 11,109,855. Enofix™ with Constrictor® Technology is manufactured by Dunamis Medical LLC
Dr. Nowak is a paid consultant of Enovis.
1. Data on File, Dunamis Medical®